Randomized Trial of Telehealth vs Conventional Hearing Care Delivery in the ACHIEVE Study
ACHIEVE 研究中远程医疗与传统听力保健服务的随机试验
基本信息
- 批准号:10626871
- 负责人:
- 金额:$ 61.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAgeAgingAreaAudiologyCOVID-19 pandemicCaringChronicClinicClinicalCognitiveCommunicationCommunitiesComplementCongressesControl LocusCountyDementiaEducationElderlyEvaluationFollow-Up StudiesFundingFutureGoalsHealthHealth EducatorsHealthcareHearingHearing AidsHourImpaired cognitionIndividualInterventionInvestmentsMeasuresMedicareMental HealthModelingOutcomeOutcome MeasureParticipantPatient-Focused OutcomesPatientsPersonsPhysical FunctionPoliciesProviderPsychological reinforcementRandomizedReportingResearch PersonnelResourcesRisk FactorsRoleSamplingSelf EfficacySelf ManagementService delivery modelServicesSiteSocial FunctioningSpecific qualifier valueTechnologyTimeTransportationVisitWashingtonarmcare deliverycare systemsclinical carecognitive functioncohortefficacy trialfollow-upfunctional outcomesgroup interventionhealth care modelhealthy aginghearing impairmenthearing loss treatmentimprovedmental functionmodifiable riskmulti-site trialpatient orientedpost interventionprimary outcomeracial diversityrandomized trialrecruitsecondary outcomestemtelehealthuptake
项目摘要
PROJECT SUMMARY
Hearing loss is a chronic condition prevalent in two-thirds of adults >70 years and may be a potentially
modifiable risk factor for adverse health outcomes including dementia. However, uptake and sustained use of
hearing aids in adults is low, with <20% of older adults with hearing loss reporting use, among whom up to 30-
40% may discontinue hearing aid use over time. These limitations may stem in part from the reliance of the
current best-practice model of hearing healthcare (HHC) on clinic-based visits that requires multiple in-person
sessions between an audiologist and a patient for all ongoing technical and self-management support services.
Incorporation of asynchronous and synchronous telehealth into HHC to complement clinic-based visits would
allow for routine troubleshooting of communication challenges, hearing aid technical issues, and reinforcement
of self-management support strategies. Determining if a HHC model that incorporates audiological telehealth
improves long-term hearing aid use and other patient-centered outcome measures has direct implications for
both future clinical care standards and ongoing Medicare legislative bills pertaining to HHC coverage. Our
interdisciplinary consortium of investigators has a singular opportunity to evaluate the potential benefits of a
telehealth audiology model on long-term hearing aid use and other outcomes in a large cohort of racially-
diverse, community-dwelling older adults who are existing hearing aid users. In the ongoing Aging & Cognitive
Health Evaluation in Elders (ACHIEVE) randomized trial, we recruited 977 adults ages 70-84 with untreated
mild-to-moderate hearing loss from January 2018 to October 2019 who were randomized 1:1 to a hearing
intervention (i.e., conventional clinic-based delivery of hearing services and technologies) versus a successful
aging education control intervention. Participants are now being followed for 3 years post-randomization at the
four ACHIEVE field sites, and the goal of this NIA-funded multisite trial (R01AG055426) is to determine if
hearing loss treatment versus an aging education control intervention reduces cognitive decline. From 2021-
2022, as participants in the hearing intervention group (n=490) complete their pre-specified three years of
follow-up in the ACHIEVE trial, we propose to recruit these existing hearing aid users and randomize them to
receive either continued conventional clinic-based delivery of hearing care services or a model that
incorporates telehealth. At 1 year post-randomization, the primary outcome (hours of hearing aid use) will be
contrasted between the two groups, and participants in the conventional HHC arm will then cross-over and
also receive telehealth HHC. All participants will continue to be followed for 2 years post-randomization. Aim 1:
To compare the effect of the telehealth versus conventional HHC delivery model on hours of hearing aid use
(primary outcome) and other patient-centered hearing and communication outcomes at 1 year post-
randomization. Aim 2: To compare the effect of the telehealth versus the conventional HHC delivery model on
secondary outcomes of social, mental, physical, and cognitive functioning at 1 year post-randomization.
项目概要
听力损失是一种慢性疾病,在 70 岁以上的成年人中普遍存在,并且可能是一种潜在的疾病
包括痴呆症在内的不良健康结果的可改变风险因素。然而,吸收和持续使用
成人使用助听器的比例较低,有听力损失的老年人报告使用助听器的比例低于 20%,其中高达 30-
40% 的人可能会随着时间的推移停止使用助听器。这些限制可能部分源于对
当前听力保健 (HHC) 的最佳实践模式是基于诊所的就诊,需要多次亲自到场
听力学家和患者之间的会议,以获取所有持续的技术和自我管理支持服务。
将异步和同步远程医疗纳入 HHC 以补充基于诊所的就诊将
允许对沟通挑战、助听器技术问题和强化进行日常故障排除
自我管理支持策略。确定 HHC 模型是否包含听力学远程医疗
改善长期助听器的使用和其他以患者为中心的结果测量对
未来的临床护理标准和正在进行的与 HHC 覆盖范围相关的 Medicare 立法法案。我们的
跨学科研究人员联盟有一个独特的机会来评估一个项目的潜在好处
关于长期助听器使用和一大群种族群体的其他结果的远程医疗听力学模型
现有助听器使用者的多元化社区老年人。在正在进行的老龄化与认知
老年人健康评估 (ACHIEVE) 随机试验,我们招募了 977 名年龄在 70-84 岁且未经治疗的成年人
2018 年 1 月至 2019 年 10 月期间有轻度至中度听力损失的患者,按照 1:1 的比例随机分配到听证会
干预(即传统的基于临床的听力服务和技术提供)与成功的干预
老龄化教育控制干预。参与者在随机分组后被跟踪 3 年
四个 ACHIEVE 现场试验,这项由 NIA 资助的多试验点试验 (R01AG055426) 的目标是确定是否
听力损失治疗与老龄化教育控制干预相比可以减少认知能力下降。 2021年-
2022 年,听力干预组的参与者 (n=490) 完成预先指定的三年
在 ACHIEVE 试验的后续阶段,我们建议招募这些现有的助听器用户并将他们随机分组
接受持续传统的基于诊所的听力保健服务或模式
纳入远程医疗。随机分组后 1 年,主要结果(助听器使用时间)将是
在两组之间进行对比,然后传统 HHC 组的参与者将交叉并
还接受远程医疗 HHC。所有参与者将在随机分组后继续接受随访 2 年。目标 1:
比较远程医疗与传统 HHC 交付模式对助听器使用时间的影响
(主要结果)以及术后 1 年其他以患者为中心的听力和沟通结果
随机化。目标 2:比较远程医疗与传统 HHC 服务模式的效果
随机化后一年的社会、心理、身体和认知功能的次要结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANK R LIN其他文献
FRANK R LIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANK R LIN', 18)}}的其他基金
Randomized Trial of Telehealth vs Conventional Hearing Care Delivery in the ACHIEVE Study
ACHIEVE 研究中远程医疗与传统听力保健服务的随机试验
- 批准号:
10183718 - 财政年份:2021
- 资助金额:
$ 61.39万 - 项目类别:
Randomized Trial of Telehealth vs Conventional Hearing Care Delivery in the ACHIEVE Study
ACHIEVE 研究中远程医疗与传统听力保健服务的随机试验
- 批准号:
10462590 - 财政年份:2021
- 资助金额:
$ 61.39万 - 项目类别:
Hearing loss, brain aging, and speech-in-noise performance in the ACHIEVE study
ACHIEVE 研究中的听力损失、大脑老化和噪声中的言语表现
- 批准号:
9768308 - 财政年份:2018
- 资助金额:
$ 61.39万 - 项目类别:
Hearing loss, brain aging, and speech-in-noise performance in the ACHIEVE study
ACHIEVE 研究中的听力损失、大脑老化和噪声中的言语表现
- 批准号:
10199916 - 财政年份:2018
- 资助金额:
$ 61.39万 - 项目类别:
Hearing loss, brain aging, and speech-in-noise performance in the ACHIEVE study
ACHIEVE 研究中的听力损失、大脑老化和噪声中的言语表现
- 批准号:
10461040 - 财政年份:2018
- 资助金额:
$ 61.39万 - 项目类别:
Implementing a Community Health Worker Model for Providing Hearing Healthcare Services to Older Adults
实施社区卫生工作者模式,为老年人提供听力保健服务
- 批准号:
9369472 - 财政年份:2015
- 资助金额:
$ 61.39万 - 项目类别:
Extending Affordable, Accessible, Community-Delivered Hearing Care to Home Care
将经济实惠、方便、社区提供的听力护理扩展到家庭护理
- 批准号:
10018204 - 财政年份:2015
- 资助金额:
$ 61.39万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 61.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 61.39万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 61.39万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 61.39万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 61.39万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 61.39万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 61.39万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 61.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 61.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 61.39万 - 项目类别:
Operating Grants